Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)

by van Rossum MAJ, van Suijlekom-Smit LWA, Allaart CF, Brinkman DMC DMC, Brederije I, Muller PCE, ten Cate R
Published 2011-09-01

Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis: <url>http://www.abc-register.nl</url>

by Prince FHM, Ferket IS, Kamphuis SSM, Armbrust W, Ten Cate R, Hoppenreijs EPAH, Koopman-Keemink Y, van Rossum MAJ, van Santen-Hoeufft M, Twilt M, van Suijlekom-Smit LWA
Published 2008-09-01

The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis

by Albers HM, Kurreeman FAS, Houwing-Duistermaat JJ, Brinkman DMC, Kamphuis SSM, Girschick HJ, Wouters C, van Rossum MAJ, Verduyn W, Toes REM, Huizinga TWJ, Schilham MW, ten Cate R
Published 2008-09-01

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis

by Prince FHM, Twilt M, Simon SCM, van Rossum MAJ, Armbrust W, Hoppenreijs EPAH, Kamphuis SSM, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat N, ten Cate R, van Suijlekom-Smit LWA
Published 2008-09-01

Association of the <it>CCR5</it>Δ32 variant with juvenile idiopathic arthritis in a meta-analysis

by Toes REM, Houwing-Duistermaat JJ, Saurenmann RK, Wouters C, Girschick HJ, Hoppenreijs EPAH, van Rossum MAJ, Kamphuis SSM, Brinkman DMC, Albers HM, Reinards THCM, Huizinga TWJ, ten Cate R, Schilham MW
Published 2011-09-01

Etanercept in juvenile idiopathic arthritis: Who will benefit?

by van den Berg JM, Swart JF, Dolman KM, Gorter SL, Koopman-Keemink Y, Twilt M, Hoppenreijs EPAH, ten Cate R, Armbrust W, Prince FHM, Otten MH, Wulffraat NM, van Rossum MAJ, van Suijlekom-Smit LWA
Published 2011-09-01